London · Delayed Price · Currency is GBP · Price in GBX Cirata Earnings Call Transcripts
Fiscal Year 2026
-
Q3 had no new logos and closing ACV was virtually unchanged QoQ as key contract decisions moved toward Q4. FY26 guidance is unchanged, but cash flow breakeven may be delayed by contract timing and collections; Symphony is advancing toward production and enterprise adoption.
-
Raised $7.2M in an oversubscribed round, strengthening the balance sheet and supporting growth. Q2 ACV rose to GBP 5.3M, driven by existing customers, with no new logos closed. Focus remains on converting a robust pipeline, aided by a new IBM OEM agreement.
-
Positive cash flow achieved in Q1 FY 2026, driven by operational discipline and strong FY 2025 growth. Cirata Symphony is gaining traction in enterprise data orchestration, with improved KPIs and a robust pipeline expected to convert in H2.
Fiscal Year 2025
-
Record bookings and cost reductions in FY 2025, highlighted by major contracts and the launch of a new data orchestration platform, position the business for sustainable growth. FY 2026 targets include cash flow positivity and continued expansion, despite lumpy enterprise sales cycles.
-
Q3 FY25 saw strategic progress with the divestment of DevOps, cost reductions, and the launch of Cirata Symphony. Data integration bookings surged, highlighted by a record $3.1M contract, while cost discipline and a new CRO position the company for sustainable growth.
-
Revenue grew over 40% and bookings rose 58% year-on-year, with sharp cost reductions and a halved adjusted EBITDA loss. Focus has shifted to data integration, supported by strategic divestitures and new leadership, with strong H2 growth and product expansion expected.
-
Secured the largest contract in company history, validating product improvements and the IBM partnership. Cost reductions and strong Data Integration growth signal a shift from recovery to growth, with guidance withdrawn pending further updates.
Fiscal Year 2024
-
Revenue grew to $3.4M in H1 with improved EBITDA loss and a 55% cost base reduction. Bookings guidance for FY 2024 is $13–$15M, with Q4 expected to be heavily weighted and a focus on profitable growth. Operating leverage and product-market fit validated by customer and partner feedback.